SARS-CoV-2-IN-112
SARS-CoV-2-IN-112 (Compound 6f) is an orally active and non-peptidic SARS-CoV-2 main protease inhibitor with an IC50 of 6.48 μM. SARS-CoV-2-IN-11 has potent antiviral activity with low cytotoxicity against WI-38 cells (IC50: 53.81 μM). SARS-CoV-2-IN-112 can be used for coronaviruses COVID-19 research.
For research use only. We do not sell to patients.
- Formula: C21H19ClN4O4S2
- Molecular Weight:490.98
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Chemical Information
-
Molecular Weight 490.98
-
Formula C21H19ClN4O4S2
-
SMILES
ClC1=CC=C(C=C1)NC(NNC(C2=CC=C(C=C2)NS(=O)(C3=CC=C(C=C3)OC)=O)=O)=S
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)